ClinicalTrials.Veeva

Menu
C

Cedar Crosse Research Center | Chicago, IL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dapagliflozin
Empagliflozin
BMS-512148
PS433540
BI 690517
Metformin
ABP-450
Ramipril
Firibastat
Polypill

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 45 total trials

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the treatme...

Active, not recruiting
Acute Migraine
Drug: Placebo
Drug: Elismetrep (K-304) Dose level 3

The study will be a multi-center, randomized clinical trial to evaluate the safety and efficacy of using the Zona Plus handgrip therapy device compar...

Enrolling
Hypertension
Elevated Blood Pressure
Device: Zona Plus Device
Other: Relaxing Music App

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic...

Enrolling
Chronic Migraine
Other: Placebo
Biological: Botulinum toxin type A

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing episodic...

Enrolling
Episodic Migraine
Other: Placebo
Biological: Botulinum toxin type A

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide
Recently updated

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Begins enrollment this month
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

A Phase 1/ 2 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokine...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: BMF-219

This is a Phase 2 dose-titration study designed to evaluate the safety and efficacy of MANP subcutaneous injection compared to placebo in reducing ba...

Enrolling
Difficult to Control Hypertension
Drug: MANP
Other: Placebo Matched control

Trial sponsors

AstraZeneca logo
Pfizer logo
Boehringer Ingelheim logo
G
A
Allergan logo
Ipsen logo
L
A
Astellas logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems